BACKGROUND: In women, anti-Müllerian hormone (AMH) levels may represent the ovarian follicular pool and could be a useful marker of ovarian reserve. The clinical application of AMH measurement has been proposed in the prediction of quantitative and qualitative aspects in assisted reproductive technologies (ART). In men AMH is secreted in both the serum and seminal fluid. Its measurement may be useful in clinical evaluation of the infertile male. METHODS: The PubMed database was systematically searched for studies published until the end of January 2009, search criteria relevant to AMH, ovarian reserve, ovarian response to gonadotrophin stimulation, spermatogenesis and azoospermia were used. RESULTS: AMH seems to be a better marker in predicting ovarian response to controlled ovarian stimulation than age of the patient, FSH, estradiol and inhibin B. A similar performance for AMH and antral follicular count has been reported. In clinical practice, AMH measurement may be useful in the prediction of poor response and cycle cancellation and also of hyper-response and ovarian hyperstimulation syndrome. In the male, the wide overlap of AMH values between controls and infertile men precludes this hormone from being a useful marker of spermatogenesis. CONCLUSIONS: As AMH may permit the identification of both the extremes of ovarian stimulation, a possible role for its measurement may be in the individualization of treatment strategies in order to reduce the clinical risk of ART along with optimized treatment burden. It is fundamental to clarify the cost/benefit of its use in ovarian reserve testing. Regarding the role of AMH in the evaluation of infertile men, AMH as single marker of spermatogenesis does not seem to reach a satisfactory clinical utility.

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) / Marca, A. L.; G., Sighinolfi; Radi, Daniele; C., Argento; E., Baraldi; A. C., Artenisio; G., Stabile; Volpe, Annibale. - In: HUMAN REPRODUCTION UPDATE. - ISSN 1355-4786. - STAMPA. - 16:2(2010), pp. 113-130. [10.1093/humupd/dmp036]

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

A. L. Marca;RADI, Daniele;VOLPE, Annibale
2010-01-01

Abstract

BACKGROUND: In women, anti-Müllerian hormone (AMH) levels may represent the ovarian follicular pool and could be a useful marker of ovarian reserve. The clinical application of AMH measurement has been proposed in the prediction of quantitative and qualitative aspects in assisted reproductive technologies (ART). In men AMH is secreted in both the serum and seminal fluid. Its measurement may be useful in clinical evaluation of the infertile male. METHODS: The PubMed database was systematically searched for studies published until the end of January 2009, search criteria relevant to AMH, ovarian reserve, ovarian response to gonadotrophin stimulation, spermatogenesis and azoospermia were used. RESULTS: AMH seems to be a better marker in predicting ovarian response to controlled ovarian stimulation than age of the patient, FSH, estradiol and inhibin B. A similar performance for AMH and antral follicular count has been reported. In clinical practice, AMH measurement may be useful in the prediction of poor response and cycle cancellation and also of hyper-response and ovarian hyperstimulation syndrome. In the male, the wide overlap of AMH values between controls and infertile men precludes this hormone from being a useful marker of spermatogenesis. CONCLUSIONS: As AMH may permit the identification of both the extremes of ovarian stimulation, a possible role for its measurement may be in the individualization of treatment strategies in order to reduce the clinical risk of ART along with optimized treatment burden. It is fundamental to clarify the cost/benefit of its use in ovarian reserve testing. Regarding the role of AMH in the evaluation of infertile men, AMH as single marker of spermatogenesis does not seem to reach a satisfactory clinical utility.
30-set-2009
16
2
113
130
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) / Marca, A. L.; G., Sighinolfi; Radi, Daniele; C., Argento; E., Baraldi; A. C., Artenisio; G., Stabile; Volpe, Annibale. - In: HUMAN REPRODUCTION UPDATE. - ISSN 1355-4786. - STAMPA. - 16:2(2010), pp. 113-130. [10.1093/humupd/dmp036]
Marca, A. L.; G., Sighinolfi; Radi, Daniele; C., Argento; E., Baraldi; A. C., Artenisio; G., Stabile; Volpe, Annibale
File in questo prodotto:
File Dimensione Formato  
la marca 2.pdf

Accesso riservato

Tipologia: Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione 371.83 kB
Formato Adobe PDF
371.83 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/640765
Citazioni
  • ???jsp.display-item.citation.pmc??? 203
  • Scopus 671
  • ???jsp.display-item.citation.isi??? 596
social impact